Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors
Laurel B. Darragh, Jacob Gadwa, Tiffany Pham, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Emerging evidence for adapting radiotherapy to immunotherapy
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 543-557
Closed Access | Times Cited: 169
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
Bradley J. Monk, Takafumi Toita, Xiaohua Wu, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 12, pp. 1334-1348
Closed Access | Times Cited: 104
Radiotherapy and immunology
Liangliang Wang, Connor Lynch, Sean P. Pitroda, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 7
Open Access | Times Cited: 22
Radiotherapy, immunity, and immune checkpoint inhibitors
Connor Lynch, Sean P. Pitroda, Ralph R. Weichselbaum
The Lancet Oncology (2024) Vol. 25, Iss. 8, pp. e352-e362
Closed Access | Times Cited: 19
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer
Ari J. Rosenberg, Nishant Agrawal, Aditya Juloori, et al.
JAMA Oncology (2024) Vol. 10, Iss. 7, pp. 923-923
Closed Access | Times Cited: 16
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial
Manuel Rodrigues, Giulia Vanoni, Pierre Loap, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34
Immunotargeting of Cancer Stem Cells
Ayşe Sedef Köseer, Simona Di Gaetano, Claudia Arndt, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1608-1608
Open Access | Times Cited: 29
Delayed tumor-draining lymph node irradiation preserves the efficacy of combined radiotherapy and immune checkpoint blockade in models of metastatic disease
Irma Telarović, Carmen S. Yong, Lisa Kurz, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): a single-arm phase Ib clinical trial
Ning Jiang, Jingyuan Zhang, Zhen Guo, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008229-e008229
Open Access | Times Cited: 10
Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs
Laurel B. Darragh, Alexander Nguyen, Tiffany Pham, et al.
Med (2024) Vol. 5, Iss. 3, pp. 254-270.e8
Closed Access | Times Cited: 10
Reduced-Volume Irradiation of Uninvolved Neck in Patients With Nasopharyngeal Cancer: Updated Results From an Open-Label, Noninferiority, Multicenter, Randomized Phase III Trial
Cheng‐long Huang, Ning Zhang, Wei Jiang, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 17, pp. 2021-2025
Closed Access | Times Cited: 9
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial
Yvonne M. Mowery, Karla V. Ballman, Angela Hong, et al.
The Lancet (2024) Vol. 404, Iss. 10467, pp. 2053-2064
Closed Access | Times Cited: 9
Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders
Pui Lam Yip, Rui You, Ming‐Yuan Chen, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 383-383
Open Access | Times Cited: 8
Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade
Justin C. Jagodinsky, Jessica M. Vera, Won Jong Jin, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 765
Open Access | Times Cited: 8
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial
Jyoti Mayadev, Dmitriy Zamarin, Wei Deng, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial
Lei Cheng, Guan-Qun Zhou, Wen-Fei Li, et al.
Cancer Cell (2025)
Open Access | Times Cited: 1
PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy
Yan-Pei Zhang, Ze-Qin Guo, Xiao-Ting Cai, et al.
Cancer Cell (2025)
Closed Access | Times Cited: 1
Lymph node metastasis in oral squamous cell carcinoma: Where we are and where we are going
Lei‐Ming Cao, Nian‐Nian Zhong, Zi‐Zhan Li, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 4
Open Access | Times Cited: 16
Immune modulatory roles of radioimmunotherapy: biological principles and clinical prospects
Xuefeng Wang, Yu Wang, Yonggang Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Efficacy and Quality-of-Life Following Involved Nodal Radiotherapy for Head and Neck Squamous Cell Carcinoma: The INRT-AIR Phase II Clinical Trial
David J. Sher, Dominic H. Moon, Dat T. Vo, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 17, pp. 3284-3291
Open Access | Times Cited: 14
High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial
Ting Martin, Deborah J. Wong, Wanxing Chai‐Ho, et al.
International Journal of Radiation Oncology*Biology*Physics (2023) Vol. 117, Iss. 2, pp. 348-354
Closed Access | Times Cited: 13
Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities
Yibin Dai, Ziyu Wang, Yingchao Xia, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 15, pp. 2845-2858
Open Access | Times Cited: 13
Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pancreatic cancer treatment
Yifan Luo, Chao Li, Yiwen Zhang, et al.
Acta Biomaterialia (2023) Vol. 167, pp. 387-400
Open Access | Times Cited: 13
Selective targeting of IL2Rβγ combined with radiotherapy triggers CD8- and NK-mediated immunity, abrogating metastasis in HNSCC
Jacob Gadwa, Maria Amann, Thomas E. Bickett, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 8, pp. 101150-101150
Open Access | Times Cited: 13
Tumor-draining lymph nodes: opportunities, challenges, and future directions in colorectal cancer immunotherapy
Yao Wang, Tingting Zhu, Qi Shi, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008026-e008026
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top